Boundary Capital Partners LLP
VC Fund
London, United Kingdom
Boundary Capital Partners LLP is a VC fund in London focused on Health Care and Software. Boundary Capital Partners is a venture capital company focusing on early stage growth companies, primarily in the technology space.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 19%
- Fund size:
- $330M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Boundary Capital Partners LLP invests in
Stages Boundary Capital Partners LLP invests in
Countries Boundary Capital Partners LLP invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $131k–$458k
- Series A
- $2M–$4.4M
Investment Focus
Industry
- Health Care 6 (22%)
- Software 5 (19%)
- Biotechnology 5 (19%)
- Medical Device 5 (19%)
- Medical 4 (15%)
Stage
- Seed 9 (33%)
- Funding Round 7 (26%)
- Series A 2 (7%)
- Series C 1 (4%)
- Post-IPO Equity 1 (4%)
Country
- United Kingdom 18 (67%)
- United States 2 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Adrian Parton
Partner
|
Partner | Total investments: 1 | Find email | |
|
Damo Baliga
Partner
|
Partner | Total investments: 0 | Find email | |
Dan Somers
Partner
|
Partner | Total investments: 2 | Find email | |
|
David Gee
Partner
|
Partner | Total investments: 0 | Find email | |
|
Ernie Richardson
Chairman & Partners
|
Chairman & Partners | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
4D Medicine
|
4D Medicine focuses on providing biomaterials and medical device solutions, particularly in the area of bioresorbable polymers. The company specializes in developing materials for 3D printing for medical applications, such as implants and devices that naturally dissolve in the body. It collaborates with partners to enhance innovation in the designand manufacturing processes for medical devices. Additionally, it offers design services to support commercial partners in advancing product development. | $4.4M / Series A / Jul 25, 2024 | |
Bodyswaps
|
Bodyswaps is a platform that empowers organizations of all sizes to upskill their workforce for the new world of work, rapidly, cost-effectively and at scale. The solution leverages VR, AI and Behavioral Science to combine the effectiveness of roleplay with the scalability of digital solutions. It simulates realistic workplace scenarios to letlearners practice their soft skills with virtual characters using their own voice, and provides them with automated personalised recommendations.Bodyswaps was founded in 2019 and is headquartered in London, England (UK). | $1.7M / Seed / Mar 29, 2022 | |
Glyconics
|
Glyconics Ltd is an innovative diagnostics company which has developed a novel approach to the diagnosis and monitoring of chronic and acute diseases including respiratory disease. The new device uses fourier transform infrared spectroscopy (FITR) to analyse sputum (saliva) samples for specific biomarkers, characteristic of chronic obstructivepulmonary disease (COPD). | $2M / Series A / Nov 18, 2021 | |
|
Glyconics
|
Glyconics Ltd is an innovative diagnostics company which has developed a novel approach to the diagnosis and monitoring of chronic and acute diseases including respiratory disease. The new device uses fourier transform infrared spectroscopy (FITR) to analyse sputum (saliva) samples for specific biomarkers, characteristic of chronic obstructivepulmonary disease (COPD). | $2M / Series A / Nov 18, 2021 | |
Inotec AMD
|
Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound.NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air anddirects it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way. | Feb 19, 2020 | |
Natrox
|
Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound.NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air anddirects it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way. | $9M / Venture - Series Unknown / Feb 19, 2020 | |
Torsion Information Security
|
Torsion delivers Confident Data Access Control. It helps you get control of who has access to what, why and when – among massive collections of files, folders and sites. Access to files and folders sprawls much faster than it is controlled. Constant sharing with little visibility or control of who has access to what, leads to significant securityand compliance challenges.Torsion integrates with your existing collaboration systems, working with business users to monitor and control access as circumstances constantly evolve. Working across Microsoft Teams, SharePoint, Office 365 and File Share systems – to improve data security and simplify compliance. Unlike traditional data governance tools, Torsion focusses on the people in the business, to help them use information securely. Business users, not IT, are best positioned to understand who needs access to their information, and so we empower them without slowing them down.Torsion’s unique solution is cloud-first, smooth to deploy and affordable for businesses of all sizes. | $458K / Seed / Jan 01, 2018 | |
Precision Sports Technologies
|
Precision Sports Technologies is specialized in the development of elite sports training and medical systems. It allows elite athletes, sports teams, and their medical staff to monitor the physiological metrics for performance, rehabilitation, and further medical needs during real-time usage.Precision Sports Technologies was founded in 2012 andis based in London, United Kingdom. | $157K / Oct 01, 2016 | |
Enigma Digital
|
We are experts in developing world-leading data recovery solutions for consumers. Our solutions are designed for desktop computers, smartphones, and tablets and can be distributed through electronic download and SaaS. For more information on our applications and what we can develop with you please email info@infinity-wireless.com | $196K / Seed / Oct 01, 2016 | |
Warwick Analytics
|
Warwick Analytics offers advanced predictive analytics and process automation. Using Warwick Analytic's proprietary technology Optimised Learning, Its flagship product, PrediCX, automatically classifies data involving a lot of text by using machine learning to label concepts rather than rules/concepts, and requires minimum human effortfor maximum accuracy. PrediCX can be used for enhanced insight into verbatim text data, Robotic Process Automation, or sentiment analysis for consumer feedback. | $1.1M / Apr 01, 2016 | |
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Boundary Capital Partners LLP invest in?
Boundary Capital Partners LLP invests primarily in Health Care, Software and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 27 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Boundary Capital Partners LLP's check size?
Boundary Capital Partners LLP typically joins rounds of $131k–$458k at Seed and $2M–$4.4M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Boundary Capital Partners LLP participates in.
How do I contact Boundary Capital Partners LLP?
Public channels for Boundary Capital Partners LLP include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Boundary Capital Partners LLP?
The team at Boundary Capital Partners LLP includes Adrian Parton (Partner), Damo Baliga (Partner) and Dan Somers (Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
